/PRNewswire/ Voltron Therapeutics, Inc., a Lucius Partners portfolio company, today announced that data from the previously announce Study 098 demonstrated.
/PRNewswire/ Voltron Therapeutics, Inc. today announced that life science veteran, Dr. Tony Hodges, has joined the Company as Senior Scientific Advisor. Dr..
/PRNewswire/ Voltron Therapeutics, Inc. today announced that life science veteran, Dr. Tony Hodges, has joined the Company as Senior Scientific Advisor. Dr..
/PRNewswire/ Lucius Partners, LLC today reported that its portfolio company, Voltron Therapeutics, Inc., had announced the initiation of a preclinical study.